Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

532 ARTÍCULOS , VIENDO DEL 331 AL 345

BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain

Sur C, Kost J, Scott D, Adamczuk K, Fox NC, Cummings JL, Tariot PN, Aisen PS, Vellas B, Voss T, Mahoney E, Mukai Y, Kennedy ME, Lines C, Michelson D, Egan MF.

Brain. 2020 Dec 1;143(12):3816-3826. doi: 10.1093/brain/awaa332.

Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The Implication of Nanotechnology

Shabbir U, Rubab M, Tyagi A, Oh DH.

Int J Mol Sci. 2020 Dec 27;22(1):196. doi: 10.3390/ijms22010196.

Rhizoma Coptidis for Alzheimer's Disease and Vascular Dementia: A Literature Review

Wang Z, Yang Y, Liu M, Wei Y, Liu J, Pei H, Li H.

Curr Vasc Pharmacol. 2020;18(4):358-368. doi: 10.2174/1570161117666190710151545.

Is Ongoing Anticholinergic Burden Associated With Greater Cognitive Decline and Dementia Severity in Mild to Moderate Alzheimer's Disease?

Dyer AH, Murphy C, Segurado R, Lawlor B, Kennelly SP; NILVAD Study Group.

J Gerontol A Biol Sci Med Sci. 2020 Apr 17;75(5):987-994. doi: 10.1093/gerona/glz244.

A Pilot Study Comparing Effects of Bifrontal Versus Bitemporal Transcranial Direct Current Stimulation in Mild Cognitive Impairment and Mild Alzheimer Disease

Liu CS, Herrmann N, Gallagher D, Rajji TK, Kiss A, Vieira D, Lanctôt KL.

J ECT. 2020 Sep;36(3):211-215. doi: 10.1097/YCT.0000000000000639.

Chromium picolinate attenuates cognitive deficit in ICV-STZ rat paradigm of sporadic Alzheimer's-like dementia via targeting neuroinflammatory and IRS-1/PI3K/AKT/GSK-3β pathway

Akhtar A, Dhaliwal J, Saroj P, Uniyal A, Bishnoi M, Sah SP.

Inflammopharmacology. 2020 Apr;28(2):385-400. doi: 10.1007/s10787-019-00681-7. Epub 2020 Jan 3.

Efficacy and Safety of Psychostimulants for Alzheimer's Disease: A Systematic Review and Meta-Analysis

Kishi T, Sakuma K, Iwata N.

Pharmacopsychiatry. 2020 Apr;53(3):109-114. doi: 10.1055/a-1076-8228. Epub 2020 Jan 30.

Antiviral therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial

Devanand DP, Andrews H, Kreisl WC, Razlighi Q, Gershon A, Stern Y, Mintz A, Wisniewski T, Acosta E, Pollina J, Katsikoumbas M, Bell KL, Pelton GH, Deliyannides D, Prasad KM, Huey ED.

BMJ Open. 2020 Feb 6;10(2):e032112. doi: 10.1136/bmjopen-2019-032112.

An evaluation of hydromethylthionine as a treatment option for Alzheimer's disease

Hashweh NN, Bartochowski Z, Khoury R, Grossberg GT.

Expert Opin Pharmacother. 2020 Apr;21(6):619-627. doi: 10.1080/14656566.2020.1719066. Epub 2020 Feb 8.

Impact of HMGB1, RAGE, and TLR4 in Alzheimer's Disease (AD): From Risk Factors to Therapeutic Targeting

Paudel YN, Angelopoulou E, Piperi C, Othman I, Aamir K, Shaikh MF.

Cells. 2020 Feb 7;9(2):383. doi: 10.3390/cells9020383.

The Interactions Between Alzheimer's Disease and Major Depression: Role of Ca(2+) Channel Blockers and Ca(2+)/cAMP Signalling

Bergantin LB.

Curr Drug Res Rev. 2020;12(2):97-102. doi: 10.2174/2589977512666200217093356.

A Systematic Review of Clinical Studies on the Effect of Psychoactive Cannabinoids in Psychiatric Conditions in Alzheimer Dementia

Paunescu H, Dima L, Ghita I, Coman L, Ifteni PI, Fulga I, Coman OA.

Am J Ther. 2020 May/Jun;27(3):e249-e269. doi: 10.1097/MJT.0000000000001120.

Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment

Lombardi G, Crescioli G, Cavedo E, Lucenteforte E, Casazza G, Bellatorre AG, Lista C, Costantino G, Frisoni G, Virgili G, Filippini G.

Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD009628. doi: 10.1002/14651858.CD009628.pub2.

Oxidative Stress in the Pathogenesis of Alzheimer's Disease and Cerebrovascular Disease with Therapeutic Implications

Jurcau A, Simion A.

CNS Neurol Disord Drug Targets. 2020;19(2):94-108. doi: 10.2174/1871527319666200303121016.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias